Healthcare -
Biotechnology - NASDAQ - US
$ 6.43
-2.43 %
$ 2.47 B
Market Cap
-3.8
P/E
RXRX - CASH FROM OPERATIONS
Cash from Operations RXRX - Recursion Pharmaceuticals, Inc.
-288 M
LAST VALUE
-34.70%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR